Geographic · Long-Lived Assets
Other — Long-Lived Assets
West Pharmaceutical Services Other — Long-Lived Assets increased by 5.5% to $221.90M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 5.5%, from $210.30M to $221.90M.
Analysis
StatementSegment
CategoryCapital Allocation
SignalContext dependent
VolatilityStable
First reportedQ4 2019
Last reportedQ4 2025
Rolls up toPP&E (Net)
How to read this metric
An increase suggests capital investment and expansion of operational capacity in the region, whereas a decrease may indicate asset divestiture, impairment, or depreciation outpacing new investment.
Detailed definition
This metric measures the total value of non-current, tangible, and intangible assets held by the company within the 'Oth...
Peer comparison
Comparable to 'Long-Lived Assets by Geography' disclosures provided by multinational corporations to show regional asset concentration.
Metric ID:
wst_segment_other_long_lived_assetsHistorical Data
5 periods
| Q4 '21 | Q4 '22 | Q4 '23 | Q4 '24 | Q4 '25 | |
|---|---|---|---|---|---|
| Value | $160.10M | $182.10M | $194.70M | $210.30M | $221.90M |
| QoQ Change | — | +13.7% | +6.9% | +8.0% | +5.5% |
| YoY Change | — | +13.7% | +6.9% | +8.0% | +5.5% |
Range$160.10M – $221.90M
CAGR+38.6%
Avg YoY Growth+8.5%
Median YoY Growth+7.5%
Current Streak4+ quarters growth
Similar Metrics at Other Companies
Frequently Asked Questions
- What is West Pharmaceutical Services's other — long-lived assets?
- West Pharmaceutical Services (WST) reported other — long-lived assets of $221.90M in Q4 2025.
- How has West Pharmaceutical Services's other — long-lived assets changed year-over-year?
- West Pharmaceutical Services's other — long-lived assets increased by 5.5% year-over-year, from $210.30M to $221.90M.
- What does other — long-lived assets mean?
- The total value of long-term assets located in the 'Other' geographic segment.